Hosted by STAT Brand Studio · 🇺🇸 US · EN · 15 episodes
Established thought leaders with verified media credentials.
Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.
STAT Brand Studio hosts Catalysts in Science, a business show with 15 episodes published.
Advances in oncology are creating new opportunities to deliver more personalized care for patients. In this sponsored conversation, Dr. Mika Kakefuda Derynck, Senior Vice President and Therapeutic Area Head of Oncology a
Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are approaching
Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty rippl
At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important phase
People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils findi
In this collaborative episode of The Nucleus, Dr. John Overton, vice president and chief sequencing officer at Regeneron Genetics Center (RGC), joins STAT Brand Studio’s Jesse McQuarters to explore how integrating proteo
What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead Sciences, shares how the company is tackling urgent needs in triple n
Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis, dis
The sudden passing of Dr. Stephen Harrison in 2024 marked the loss of a visionary liver disease researcher and compassionate advocate. His legacy lives on through a new fellowship program that aims to educate and empower
What does it take to bring a new therapy from concept to commercialization? In this episode, STAT Brand Studio editor Jesse McQuarters speaks with Jerry Keybl, SVP for Biopharma Products and Strategy at Avantor, about ho
New York City is investing over $1 billion to become a global leader in the life sciences — and at the heart of that mission is a commitment to infrastructure, innovation, and equity. In this episode, STAT Brand Studio e
Puerto Rico is emerging as a key biopharma hub, offering advanced manufacturing capabilities, a highly skilled workforce, and significant cost advantages. In this conversation, OcyonBio CEO Robert Salcedo discusses how h
Colorectal cancer remains the second leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how real-
NYU Grossman School of Medicine is transforming medical education with an innovative three-year medical degree and tuition-free enrollment. Senior Associate Dean Joan Cangiarella, M.D., highlights the school's commitment
Molecular testing tools, including tumor sequencing and increasingly sensitive diagnostics, are leveling up oncology by enabling precise, personalized cancer treatment. Clinicians can now detect circulating tumor DNA, as
As CEO of NYU Langone Health and dean of the Grossman School of Medicine, Dr. Robert Grossman leads a health system that excels in patient-oriented metrics, with a strategic eye toward the future. In this STAT Brand Stud
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Catalysts in Science has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.
Catalysts in Science is hosted by STAT Brand Studio. The show is categorised under business (health) and has published 15 episodes.
Catalysts in Science has published 15 episodes.
Catalysts in Science regularly covers business, health, fitness. It sits in the business category, with a health focus.
Catalysts in Science is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Catalysts in Science hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Catalysts in Science average 10 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Catalysts in Science's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 9 days ago.
